Literature DB >> 9626333

Cytokine regulation of RANTES production by human retinal pigment epithelial cells.

I J Crane1, M C Kuppner, S McKillop-Smith, R M Knott, J V Forrester.   

Abstract

The mechanism whereby inflammatory cells gain access to the retina in posterior intraocular inflammatory disease remains unclear. The chemokine RANTES has the potential to influence the migration of memory T cells and monocytes across the blood-retinal barrier during inflammatory eye disease. We have therefore examined the production of RANTES by cultured human retinal pigment epithelial cells (RPE), which form a part of the blood-retinal barrier, in response to cytokines likely to be present in the microenvironment. IL-1 beta and TNF alpha stimulated RANTES production by these cells. IFN-gamma acted synergistically with TNF alpha to increase RANTES production. In contrast, IL-4 downregulated RANTES production stimulated by TNF alpha. RT-PCR studies showed that RANTES mRNA from RPE followed the same pattern of expression in response to cytokines as did RANTES production indicating that RANTES production was controlled at, or prior to, transcription. RANTES is produced in vitro by RPE in response to the proinflammatory cytokines IL-1 beta, TNF alpha, and IFN-gamma and is therefore likely to play a role in the development of the inflammatory eye disease endogenous posterior uveitis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9626333     DOI: 10.1006/cimm.1997.1235

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  18 in total

Review 1.  Immunomodulation of autoimmune responses with monoclonal antibodies and immunoadhesins: treatment of ocular inflammatory disease in the next millennium.

Authors:  A D Dick; J D Isaacs
Journal:  Br J Ophthalmol       Date:  1999-11       Impact factor: 4.638

Review 2.  Major histocompatibility complex molecules on parenchymal cells of the target organ protect against autoimmune disease.

Authors:  Hui Shao; Henry J Kaplan; Deming Sun
Journal:  Chem Immunol Allergy       Date:  2007

3.  Cytokine regulation of granulocyte-macrophage colony-stimulating factor (GM-CSF) production by human retinal pigment epithelial cells.

Authors:  I J Crane; M C Kuppner; S McKillop-Smith; C A Wallace; J V Forrester
Journal:  Clin Exp Immunol       Date:  1999-02       Impact factor: 4.330

4.  The effect of previous surgery and topical eye drops for primary open-angle glaucoma on cytokine expression in aqueous humor.

Authors:  Lisa A Engel; Philipp S Muether; Sascha Fauser; Arno Hueber
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-03-18       Impact factor: 3.117

5.  Control of chemokine production at the blood-retina barrier.

Authors:  I J Crane; C A Wallace; S McKillop-Smith; J V Forrester
Journal:  Immunology       Date:  2000-11       Impact factor: 7.397

Review 6.  Resolution of uveitis.

Authors:  Gerhild Wildner; Maria Diedrichs-Möhring
Journal:  Semin Immunopathol       Date:  2019-10-07       Impact factor: 9.623

7.  RANTES stimulates Ca2+ mobilization and inositol trisphosphate (IP3) formation in cells transfected with G protein-coupled receptor 75.

Authors:  A Ignatov; J Robert; C Gregory-Evans; H C Schaller
Journal:  Br J Pharmacol       Date:  2006-09-25       Impact factor: 8.739

8.  Inflammatory Cytokines Induce Expression of Chemokines by Human Retinal Cells: Role in Chemokine Receptor Mediated Age-related Macular Degeneration.

Authors:  Chandrasekharam N Nagineni; Vijay K Kommineni; Nader Ganjbaksh; Krishnasai K Nagineni; John J Hooks; Barbara Detrick
Journal:  Aging Dis       Date:  2015-11-17       Impact factor: 6.745

9.  Retinal pigment epithelial cells phagocytosis of T lymphocytes: possible implication in the immune privilege of the eye.

Authors:  F Willermain; L Caspers-Velu; B Nowak; P Stordeur; R Mosselmans; I Salmon; T Velu; C Bruyns
Journal:  Br J Ophthalmol       Date:  2002-12       Impact factor: 4.638

10.  Polymorphisms of chemokine and chemokine receptor genes in idiopathic immune-mediated posterior segment uveitis.

Authors:  Muhammad A Ahad; Tom Missotten; Atiyeh Abdallah; Penny A Lympany; Susan Lightman
Journal:  Mol Vis       Date:  2007-03-23       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.